Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

What shares were hot in the last week? Argo Blockchain, Greatland Gold and more

Published 24/01/2021, 10:32
Updated 24/01/2021, 10:40
© Reuters.

© Reuters.

Argo Blockchain

Argo Blockchain PLC (LON:ARB) as UK based cryptocurrency miner, currently hosting its infrastructure in sites in North America. The share price opened the week at £0.95, hit a high of £1.01 on Tuesday before closing the week at £0.7760.

Argo Blockchain weekly chart

Greatland Gold

Greatland Gold Plc (LON:GGPL) is a mineral exploration and development company based focused on gold in Tasmania and Western Australia. The share price opened the week at £0.3275, hit a high of £0.35 on Tuesday before closing near its low of the week at £0.28.

Greatland Gold weekly chart

Synairgen

Synairgen (LON:SYNG) is a pharmaceutical company currently undertaking a Phase 2 trial of its Covid-19 inhaler treatment. Results from the trial are expected in Q2 2021. Synairgen shares opened the week at £1.64, hit a high of £1.76 on Wednesday and closed at £1.70.

Synairgen weekly chart

Eurasia Mining

Eurasia Mining (LON:EUA) is another mineral exploration company, focusing on platinum group metals, gold and other minerals in Russia. The shares opened the week at £0.3075, hit a high of £0.3343 on Thursday, before closing the week at £0.3050.

Eurasia Mining weekly chart

Novacyt

Novacyt (LON:NCYT) is a pharmaceutical company that produces in vitro and molecular diagnostic tests. The shares opened the week at £10.72, hit a high of £11.57 on Friday before closing at £11.26.

Novacyt weekly chart

Latest comments

next week pharm stocks to watch, omega diognostics and Avacta.
Results due next week
next week pharm stocks to watch, omega diognostics and Avacta.
I would like to buy stocks and holf them instead of trading them on a trading platform how can I do that?
hargreaves lansdown isn't free but but you get what you pay for
Freetrade
ii.co.uk is cheaper than HL but if holding not trading them use 212 as theres no monthly charge etc.
I would like to buy stocks and holf them instead of trading them on a trading platform how can I do that?
Trader with a broker or bank?
SNG s current SP should move quickly north on a successful phase 3 trial result due next month IMHO
do you really think the gov will allow for an inhaler 'vaccine' instead of the injectable (worth billions more) which involves the big pharmas
Sng is currently running a phase 3 trial with the first patient dosed weeks ago not just phase 2 like the artical suggested.
*Article
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.